Product category:
Filtration equipment and supplies
News Release from: P2i
Edited by the Laboratorytalk Editorial
Team on 16 April 2008
P2i attracts investment from Unilever
Ion-mask, the revolutionary super-hydrophobic treatment from P2i , has attracted substantial investment from Unilever Ventures
The additional funding will allow P2i to accelerate the introduction of its 'ground-breaking' ion-mask technology across its chosen market segments and expand its operations to maximise market penetration "The past few months have seen some amazing developments for us, not only signing our first high street customer for ion-mask but winning a prestigious Innovation award at the ISPO Show in Germany," said P2i's Business development director, Ian Robins
This article was originally published on Laboratorytalk on 19 Jul 2005 at 8.00am (UK)
Related stories
Surface enhancements promise better pipetting
Nano-thin coatings to dramatically enhances pipette performance, virtually eliminating liquid retention and delivering more accurate and reliable results which can reduce reagent costs by up to 10%
"The benefits of ion-mask enhancement are well-known in performance textiles and laboratory disposables but with this additional investment we will now be able to take ion-mask to a far wider audience".
"True technical innovation is a rarity these days but having tracked P2i's progress over the past several months we spotted something pretty revolutionary in ion-mask," added director of Unilever Ventures, Mark Muth.
"Having assessed the technology for both performance textiles and technical market segments, there's no doubt this is a world class process and we are looking forward to working with P2i to accelerate its commercial roll-out into some exciting new sectors.".
• P2i: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
